Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Clinical trial NCT01561430 · TERMINATED
Trial details
- NCT number
- NCT01561430
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-08-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.